These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8884220)

  • 41. The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia.
    Chaillet P; Coulaud A; Zajac JM; Fournie-Zaluski MC; Costentin J; Roques BP
    Eur J Pharmacol; 1984 May; 101(1-2):83-90. PubMed ID: 6086366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors.
    Notas G; Kampa M; Nifli AP; Xidakis K; Papasava D; Thermos K; Kouroumalis E; Castanas E
    Eur J Pharmacol; 2007 Jan; 555(1):1-7. PubMed ID: 17113072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynorphin 1-8 binds to opiate kappa receptors in the neurohypophysis.
    Gerstberger R; Barden N
    Neuroendocrinology; 1986; 42(5):376-82. PubMed ID: 2871501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF; Goldstein A
    Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line.
    Kampa M; Margioris AN; Hatzoglou A; Dermitzaki I; Denizot A; Henry JF; Oliver C; Gravanis A; Castanas E
    Eur J Pharmacol; 1999 Jan; 364(2-3):255-62. PubMed ID: 9932731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
    Shen KF; Crain SM
    Brain Res; 1994 Feb; 636(2):286-97. PubMed ID: 8012813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC; Loh HH; Law PY
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide.
    Van Den Bossche B; D'haeninck E; De Vos F; Dierckx RA; Van Belle S; Bracke M; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1022-30. PubMed ID: 15029461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
    Xu Y; Song J; Berelowitz M; Bruno JF
    Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth.
    Janecka A; Fichna J; Kosson P; Zalewska-Kaszubska J; Krajewska U; Mirowski M; Rozalski M
    Regul Pept; 2004 Aug; 120(1-3):237-41. PubMed ID: 15177942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides.
    Cruciani RA; Dvorkin B; Klinger HP; Makman MH
    Brain Res; 1994 Dec; 667(2):229-37. PubMed ID: 7697360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist.
    Bot G; Blake AD; Li S; Reisine T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):283-90. PubMed ID: 9435189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
    Tao PL; Tsai CL; Chang LR; Loh HH
    Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decrease in mu-opioid receptor binding capacity in rat brain after chronic PL017 treatment.
    Tao PL; Lee HY; Chang LR; Loh HH
    Brain Res; 1990 Sep; 526(2):270-5. PubMed ID: 2175241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of mu and delta opioid peptides of various selectivity gives further evidence of specific involvement of mu opioid receptors in supraspinal analgesia (tail-flick test).
    Dauge V; Petit F; Rossignol P; Roques BP
    Eur J Pharmacol; 1987 Sep; 141(2):171-8. PubMed ID: 2824213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.